A detailed history of Gitterman Wealth Management, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Gitterman Wealth Management, LLC holds 2,126 shares of BSX stock, worth $205,584. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,126
Previous 3,832 44.52%
Holding current value
$205,584
Previous $386,000 40.93%
% of portfolio
0.06%
Previous 0.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025

SELL
$89.7 - $107.41 $153,028 - $183,241
-1,706 Reduced 44.52%
2,126 $228,000
Q1 2025

May 14, 2025

SELL
$89.38 - $106.18 $11,351 - $13,484
-127 Reduced 3.21%
3,832 $386,000
Q4 2024

Feb 10, 2025

BUY
$83.62 - $91.5 $14,048 - $15,372
168 Added 4.43%
3,959 $353,000
Q3 2024

Nov 13, 2024

BUY
$72.96 - $84.0 $276,591 - $318,444
3,791 New
3,791 $317,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $138B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Gitterman Wealth Management, LLC Portfolio

Follow Gitterman Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gitterman Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gitterman Wealth Management, LLC with notifications on news.